Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 FY- Text added to 2017 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accomplished, AHCA, ahead, Alameda, alter, American, Amneal, analyzing, andecaliximab, ankylosing, antigen, arguing, argument, Arkhangai, aspect, auditor, authentic, axicabtagene, BIC, biktarvy, bNab, bowel, Bridge, broader, Bulletin, CAR, Carribean, cellular, certification, chemotherapy, chimeric, Choice, ciloleucel, conpeting, continent, copay, correctly, County, custody, cytokine, DAA, Daiichi, death, deployed, derecognition, detrimental, diffuse, disregard, divert, DLBCL, DNA, drawn, drew, dual, Eastern, El, epidemic, Evotaz, excellence, explanation, fat, GDPR, gene, governor, gravitated, greatly, harvesting, headquartered, hemifumarate, HIPAA, immigration, incidence, influence, infusing, injured, interpretation, interpreted, jeopardized, Juluca, Juno, Kettering, kg, kind, kite, knowable, Konnect, lapse, lattice, leader, Leave, led, lessen, logistical, lot, lymphoblastic, MAGE, Malaysian, mantle, marked, Mavyret, maximize, maximizing, media, mediastinal, modification, Mongolia, Monica, myeloma, neurologic, neutralizing, nivolumab, OAFLA, optimal, outlicense, overcome, overturned, owner, Pakistan, parent, PCAOB, Pennsylvania, persuading, placebo, platform, play, PMBCL, Portability, post, potency, preliminarily, preliminary, prolonged, provisional, psoriatic, pursuit, reborrowed, reclassification, refining, remote, repair, repatriated, repatriation, restore, Rim, robust, SAB, sample, Sankyo, Santa, SCLAN, Segundo, Shinogi, shipment, shortly, Sjogren, slight, slightly, Sloan, speaker, strand, strictly, strongly, switch, Symtuza, synnotch, synthetic, TFL, throttle, Tirabrutinib, tocilizumab, tool, Trump, underway, unsealed, virologically, vivo, vosevi, weather, weighing, weight, white, Writ, Yescarta, yescartatm, York
Removed:
Abelcet, abroad, accumulate, addressing, administer, allocate, Amphotec, Anfogen, Apotex, Argentina, avian, bacterial, began, bifurcated, biologic, bore, borrowing, bulk, caspofungin, cease, cholesterol, cholesteryl, clinically, commencing, composed, comprised, conventional, coordination, counseling, daily, delivered, diabetic, distributed, domestic, donate, downturn, earned, emerging, encapsulation, Enzon, equipped, ERA, export, flu, Fremont, fulfilled, Genentech, Genpharma, governed, grafting, herewith, Hetero, highest, ibrutinib, idiopathic, Imbruvica, Indian, Insider, interferon, intervention, investigating, Jersey, LEAP, length, lesser, letter, lipid, lump, mandated, meaningful, member, Minister, MPI, neuraminidase, newer, Norwegian, Olysio, omitted, operation, Oslo, owed, Pak, pandemic, partnership, pattern, peak, pegylated, prescribed, prohibited, prohibiting, prohibition, ratably, Regime, Relenza, remained, remitted, repayment, residual, secondary, Shanghai, simeprevir, similarity, SLL, splitting, sponsor, steeply, strike, sublicense, substantive, sulfate, surgical, thereto, threatening, Tobi, tobramycin, toxicological, trail, unavailable, unremitted, unrepatriated, unsafe, Vfend, Viekira, vitekta, voriconazole, zanamivir
Valuein 2016 FY filing- Value in 2017 FY filing
Original filings
Filing view